Indegene’s Post

🌟 𝐁𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐆𝐫𝐨𝐮𝐧𝐝: 𝐍𝐨𝐯𝐚𝐫𝐭𝐢𝐬 𝐈𝐧𝐝𝐢𝐚 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐰𝐢𝐭𝐡 𝐅𝐨𝐫𝐛𝐞𝐬 𝐈𝐧𝐝𝐢𝐚 𝐭𝐨 𝐏𝐫𝐨𝐩𝐞𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 Novartis India, believes in pioneering collaborations that drive innovation and industry excellence. That's why Novartis is thrilled to announce their partnership with Forbes India, a leading authority on business and finance. 𝐖𝐡𝐲 𝐅𝐨𝐫𝐛𝐞𝐬 𝐈𝐧𝐝𝐢𝐚? Forbes India stands as a beacon of insightful journalism, offering unparalleled coverage of India's business landscape. Their in-depth analyses, thought-provoking articles, and exclusive interviews with industry titans align seamlessly with our commitment to fostering knowledge and progress. 𝐖𝐡𝐲 𝐢𝐬 𝐭𝐡𝐢𝐬 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐟𝐨𝐫 𝐔𝐬? 📌 As aspiring pharmaceutical management professionals, staying ahead of industry trends and insights is crucial for our growth and success. 📌 The partnership between Novartis India and Forbes India presents an unparalleled opportunity to access cutting-edge content and thought leadership in the pharmaceutical and healthcare sectors. #NovartisIndia #ForbesIndia #IndustryInsights #Collaboration #Innovation #Healthcare

Our leaders will be at BioAsia 2024 over the next two days! Our Chairman, Satish Reddy, will be in a panel on 'Geopolitical Imperatives To Reorganise The Global Drug Supply Chains: How Did India Fare Vs. It's Potential Ambition?' #BioAsia2024

Sanofi Healthcare India is expanding its Global Capability Centre (GCC) in Hyderabad by investing Rs 3600 crore by 2030. Global Capability Centre (GCC) is like a specialized office where a company carries out important tasks and services for its business around the world. It handles things like research, development, technology support, and innovation. This expansion will boost innovation, research, and development in healthcare, and increase their workforce. The announcement was made at the new facility in Hitec City, attended by key government officials. Sanofi’s expansion supports the Telangana government's goal to make the state a top hub for healthcare innovation. This investment will make the Hyderabad GCC the largest of Sanofi's four global centers within two years, growing from 1,000 to 2,600 employees. Emmanuel Frenehard, a top executive at Sanofi, stressed the importance of using Artificial Intelligence (AI) to improve everything from drug discovery to marketing. Sanofi aims to be the first biopharma company fully powered by AI, ensuring it is used safely and ethically to speed up drug development and increase productivity. Madeliene Roach, another senior executive at Sanofi, said the investment will focus on hiring talent and developing new skills, as well as building modern facilities in Hyderabad.

📌 Check the comments section for the full News link. 🌟 India's Pharma Powerhouse: Showcasing Innovation & Global Leadership at CPHI & PMEC India 2024 The 17th edition of CPHI & PMEC India is more than just an expo—it's a celebration of India's pharmaceutical might and its pivotal role as the ‘pharmacy of the world.’ With 2,000+ exhibitors and 50,000 visitors from over 150 countries, the event is a dynamic hub for collaboration, innovation, and transformative growth. 🚀 Key Highlights: ✅ Empowering the Future: Focused discussions on sustainability, digital transformation, and women in pharma underscore the industry’s forward-thinking approach. ✅ Global Leadership: With exports to 200+ countries and projected market growth to $130 billion by 2030 and $450 billion by 2047, India continues to define global healthcare. ✅ Game-Changing Innovations: From Carticel therapy for cancer to Nafithromycin for drug-resistant pathogens, India demonstrates its expertise in affordable, effective treatments and groundbreaking solutions. ✅ Biopharma’s Rise: By 2027, biopharmaceuticals will account for 35% of the global market, with India leading the charge in both innovation and production. ✅ Strategic Collaboration: The event, supported by key associations like Pharmexcil (Pharmaceuticals Export Promotion Council of India) and Federation of Pharma Entrepreneurs (FOPE), provides an unparalleled platform for startups, disruptors, and established players to forge partnerships and drive progress. 🎯 "With strengths in cost-efficient R&D, skilled labor, and a manufacturing edge, India is positioned to shape global healthcare," said Yogesh Mudras, Managing Director of Informa Markets in India. 💡 Events like CPHI & PMEC India are more than expos—they're catalysts for transformation, driving innovation, creating synergies, and empowering the industry to reach new heights. 👏 Kudos to the organizers, exhibitors, and attendees for making this a landmark event for the pharmaceutical world. The future of global healthcare begins here! Tagging Key People - Mr.Chakravarthi AVPS,Mr. Adam Andersen #PharmaInnovation #CPHIIndia #PMECIndia #PharmaceuticalIndustry #GlobalHealthcare #Biopharma #WomenInPharma #DigitalTransformation #SustainabilityInPharma #IndiaPharma #PharmaLeaders #FutureOfHealthcare #PharmaExpo2024 #PharmaGrowth

India's healthcare innovation market may hit US$ 60 billion by FY28: Report According to a joint report by Bain & Company and HeathQuad, India's healthcare innovation market is poised to double to US$ 60 billion by fiscal year 2028. Rising consumer demand, global healthcare value chain shifts, advancements in Indian scientific capabilities, and favourable regulatory conditions fuel this growth. In FY23, the overall Indian healthcare market reached US$ 180 billion, with healthcare innovation accounting for US$ 30 billion, representing 15% of the market. While pharma services and health tech dominate innovation, emerging areas like biotech and MedTech show promise. Key highlights include the pharma services market reaching US$ 16 billion in FY23, with 85-90% of revenue from exports, and the health-tech market more than doubling to US$ 7 billion, capturing 25% of the healthcare innovation space. Vaccines and biotech, valued at US$ 4 billion, constituted 15% of the total innovation market. India's MedTech industry, a US$ 11 billion market, garnered 80% of its revenues from imports. Investment patterns in the healthcare sector have remained consistent, focusing on positive unit economics and operational efficiencies, especially in enterprise-facing segments. The report also anticipates potential consolidation across segments for smaller businesses lacking sufficient funding or a clear path to profitability. #pmoindia #pmnarendramodi #narendramodi #pharmaceutical #medtech #indianews

Which government initiatives, schemes, and programmes are currently underway to promote the pharma sector? Are you aware of the key policy impediments impacting the sustainability and growth of the sector? What policy recommendations can strengthen the pharma ecosystem and its regulatory environment ushering research and innovation in the sector? Be a part of an insightful session featuring Joydeep Ghosh, Partner, Deloitte India, at the "ASSOCHAM Annual Pharma Summit 2024" and find answers to these questions and more. Watch this space. ASSOCHAM (The Associated Chambers of Commerce and Industry of India) #PharmaInnovation #ResearchAndDevelopment #IndiaRnD

Tamarind’s recent visit to this year’s @BioAsia2024 gave us an opportunity to engage with established and start-up businesses in the life sciences and healthcare sectors. The enthusiasm on the future of the sector and the importance of India particularly on the global stage continues to inspire. It was great to be back in the pharma hub of Hyderabad to reconnect with old and new clients, as well as forge new partnerships for Tamarind Search. This was the 21st edition of this life sciences and healthcare forum in Asia, and the focus, as it is for many industries right now, was on the emerging opportunities to harness the power of data and AI. Attending BIOAsia2024 also gave our team a chance to discover the cutting-edge research, disruptive technologies, and innovative solutions emerging in the life sciences and healthcare sectors in the region. This allowed us to gain an understanding of the newest skills and technologies, so we can fully support our clients when they are hiring new talent within the pharmaceutical industry. #PharmaIndustry #BioAsia2024 #GlobalTalentSearch #TamarindSearch

Tamarind’s recent visit to this year’s @BioAsia2024 gave us an opportunity to engage with established and start-up businesses in the life sciences and healthcare sectors. The enthusiasm on the future of the sector and the importance of India particularly on the global stage continues to inspire. It was great to be back in the pharma hub of Hyderabad to reconnect with old and new clients, as well as forge new partnerships for Tamarind Search. This was the 21st edition of this life sciences and healthcare forum in Asia, and the focus, as it is for many industries right now, was on the emerging opportunities to harness the power of data and AI. Attending BIOAsia2024 also gave our team a chance to discover the cutting-edge research, disruptive technologies, and innovative solutions emerging in the life sciences and healthcare sectors in the region. This allowed us to gain an understanding of the newest skills and technologies, so we can fully support our clients when they are hiring new talent within the pharmaceutical industry. #PharmaIndustry #BioAsia2024 #GlobalTalentSearch #TamarindSearch

Only 3 Days to Go! 🔥 The Future of Pharma Awaits! Get ready for an electrifying Day 2 at CPHI & PMEC India 2024, where the spotlight is on sustainability, innovation, and game-changing solutions! 🌍✨ 🔑 What’s the buzz? 🚀 Power-packed leadership panels driving green innovation 🌱 Decarbonizing the pharma supply chain—leading the sustainability charge 🧪 Green chemistry breakthroughs revolutionizing drug development 📦 Sustainable packaging solutions that are reshaping industry standards & much more! The excitement is building, the energy is contagious, and the future of pharma is closer than ever! Are you ready to be part of the transformation? 💬 Which session are you hyped for? Tell us in the comments below! Don’t miss your chance to be part of this unmissable day! Let's turn vision into action. 💡 Informa Markets in India #CPHIPMECIndia2024 #PharmaInnovation #GreenPharmaRevolution #FutureReadyPharma #PharmaNow #PharmaLeadership #SustainabilityInPharma #PharmaEvents

𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗧𝘄𝗼 𝗮𝘁 𝗖𝗣𝗛𝗜 & 𝗣𝗠𝗘𝗖 𝗜𝗻𝗱𝗶𝗮 2024: 𝗔 𝗧𝗵𝗼𝘂𝗴𝗵𝘁-𝗣𝗿𝗼𝘃𝗼𝗸𝗶𝗻𝗴 𝗞𝗲𝘆𝗻𝗼𝘁𝗲 𝗼𝗻 𝗜𝗻𝗱𝗶𝗮 𝗮𝘀 𝘁𝗵𝗲 “𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱” The highly engaging second session, led by Rhonda Duffy, Executive Vice-President & Chief Operating Officer at Biocon Biologics, just concluded, leaving the audience with invaluable insights into India’s pivotal role in global pharma and biopharma. The keynote explored the following key themes: 1. Cost-effective therapies and manufacturing: How India leverages its strengths in affordability to lead the generics and biosimilars market. 2. Government policies and funding: The critical support driving the growth of the Indian pharma and biopharma sectors. 3. Quality and compliance at the core: Emphasizing the importance of maintaining global standards while expanding capabilities. 4. Forging partnerships and alliances: The strategic collaborations shaping India’s journey as the “Pharmacy of the World.” Dr. Duffy’s expertise and vision sparked meaningful discussions and shed light on the future of Indian pharma, highlighting the country’s leadership in delivering affordable and quality healthcare solutions globally. Stay tuned for more updates and highlights as CPHI & PMEC India 2024 continues to provide a platform for innovation, collaboration, and growth. #AtTheHeartOfPharma #CPHIAndPMECIndia2024 #PharmaLeadership #InnovationAndCollaboration #PharmaInsights Rahul Deshpande, Jayesh Kanaskar, Ketki Karkhanis, Shruti Save, Dheeresh Bangera, Sameer Matkar, Mahesh Verma, Devendra Bhosale, Kanishka Ahuja, Rohan Salian